Abstract
Atypical chronic myeloid leukemia (aCML) is a rare hematopoietic stem cell disorder, with overlapping features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). Because of its low incidence, researchers knew less about this disease. In recent years, with the increasing number of cases with aCML and the applications of next-generation sequencing technology, researchers have studied it more deeply. This article mainly summarizes the clinical and genetic characteristics, pathogenesis, diagnosis and differential diagnosis, treatment and prognosis of aCML, aiming at deepening researchers understanding of aCML and providing references for diagnosis and treatment. Key words: Leukemia, myeloid, chronic, atypical, BCR-ABL negative; Genetics; Diagnosis; Therapeutics; Pathogenesis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Blood Transfusion and Hematology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
